Arterius Ltd. was established in 2009 to exploit opportunities in the multi-billion dollar coronary stent market. The Arteriosorb™ Biodegradable Scaffold is produced using a proprietary method for enhancing the strength of the polymer tubing, and is designed to support the vessel during remodelling, and to biodegrade leaving no permanent implant.
| Website | http://www.arterius.co.uk |
| Revenue | $1 million |
| Employees | 6 (6 on RocketReach) |
| Founded | 2009 |
| Phone | +44 113 426 4300 |
| Technologies |
JavaScript
,
HTML
,
PHP
+7 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Life Science, Medical, Health Care, Medical Device, Pharmaceutical |
| Keywords | Coronary Stents, Polymer Tubing, Medical Devices, Vascular Devices, Cardiovascular Devices, Degradable Polymers, Drug Eluting Stents, Interventional Cardiology, Medical Technology, Biomaterials, Polymer Processing, Strength Enhancement, Vascular Surgery, Biomedical Engineering |
| Competitors | Johnson & Johnson, Medtronic, Abbott, Stryker, Boston Scientific, 3M, Zimmer Biomet, Smith+Nephew, B. Braun Group, Convatec Infusion Care +36 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Arterius Ltd employee's phone or email?
The Arterius Ltd annual revenue was $1 million in 2026.
Kadem al-Lamee is the Chief Technical Officer and Co-Founder of Arterius Ltd.
6 people are employed at Arterius Ltd.
The NAICS codes for Arterius Ltd are [339, 33].
The SIC codes for Arterius Ltd are [384, 38].